Impact of school-based malaria screening and treatment onP. falciparuminfection and anemia prevalence in two transmission settings in Malawi
preprint
OA: closed
CC-BY-NC-ND-4.0
Abstract
Background In areas highly endemic for malaria, Plasmodium falciparum ( Pf ) infection prevalence peaks in school-age children, adversely affecting their health and education. School-based intermittent preventive treatment reduces this burden, however concerns about cost and widespread use of antimalarial drugs have limited enthusiasm for this approach. School-based screening-and-treatment is an attractive alternative. We conducted a school-based cohort study to evaluate the impact of screening-and-treatment on the prevalence of Pf infection and anemia in two different transmission settings. Methods We screened 704 students in four Malawian primary schools for Pf infection using rapid diagnostic tests (RDTs). Those testing positive were treated with artemether-lumefantrine. Outcomes were Pf infections detected by microscopy or PCR and anemia after six weeks. Results Prevalence of infection by RDT at screening was 37% (range among schools 9-64%). We detected a significant reduction after six weeks in infections by microscopy (adjusted relative reduction (aRR) 47.1%, p<0.0001) and PCR (aRR 23.1%, p<0.0001), but no reduction in anemia. In low, seasonal prevalence areas, sub-patent infections at screening led to persistent infection, but not disease, during follow-up. In high transmission settings, new infections frequently occurred within six weeks after treatment. Conclusions School-based screening-and-treatment reduced Pf infection but not anemia. This approach could be enhanced in low transmission settings by using more sensitive screening tests and in high transmission settings by repeating the intervention or using longer acting drugs. Summary Malaria screening-and-treatment reduced P. falciparum infections but not anemia. Because rapid diagnostic tests failed to detect low-density infections, screening tests with higher sensitivity may be needed in low transmission areas where low-density infections make-up a larger proportion of infections.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-ND-4.0